Final answer:
Fetal Valproate Syndrome is a disorder caused by prenatal exposure to valproate, leading to developmental delays, distinct facial features like a thin upper lip and small eye openings, limb defects, and neurodevelopmental delays. It shares some similarities with Fetal Alcohol Syndrome, but is caused by a different teratogen.
Step-by-step explanation:
Common Features of Fetal Valproate Syndrome
Fetal Valproate Syndrome (FVS) is a condition arising from prenatal exposure to valproate, a medication often prescribed for epilepsy. Children affected by FVS may show developmental delays, distinct facial features, and other abnormalities. The facial features associated with this disorder could include a thin upper lip, small eye openings, and a smooth philtrum. These features can somewhat resemble those of Fetal Alcohol Syndrome (FAS) where alcohol is the teratogen. While the specifics of Fetal Valproate Syndrome involve other phenotypic effects such as limb defects and neurodevelopmental delays, it's important to understand that like FAS, FVS is preventable through the avoidance of valproate during pregnancy, when possible.